menu
    • menu

    Company profile for Sound Pharmaceuticals

    NEW Drugs in Dev: 1
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SPI is a pioneer in neurotologic drug development aimed at treating sensorineural diseases of the inner ear. Our expertise in molecular biology, immunohistochemistry and electrophysiology have lead to the development of preclinical models of hearing loss and tinnitus that are translating into novel and successful clinical trials. Sound Pharmaceuticals, Inc. (SPI) is developing therapeutics that will enable doctors and patient...
    SPI is a pioneer in neurotologic drug development aimed at treating sensorineural diseases of the inner ear. Our expertise in molecular biology, immunohistochemistry and electrophysiology have lead to the development of preclinical models of hearing loss and tinnitus that are translating into novel and successful clinical trials. Sound Pharmaceuticals, Inc. (SPI) is developing therapeutics that will enable doctors and patients to prevent and treat various forms of hearing loss. Sensorineural hearing loss is the third largest disease in the industrialized world and affects 50 million Americans.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sound PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4010 Stone Way N # 120 Seattle, WA 98103
    Telephone
    Telephone
    (206) 634-2559
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://soundpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sound-pharmaceuticals-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sound Pharma Gets FDA Breakthrough Status For SPI-1005
    Sound Pharma Gets FDA Breakthrough Status For SPI-1005

    01 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-01/sound-pharmaceuticals-receives-fda-breakthrough-therapy-designation-for-spi-1005-to-treat-meniere-s

    PHARMIWEB
    01 Dec 2025
    Share Share
    Sound Pharma to Speak at Life Sciences Industry Conferences
    Sound Pharma to Speak at Life Sciences Industry Conferences

    08 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250708997839/en/Sound-Pharma-to-Present-at-Upcoming-Life-Sciences-Industry-Conferences

    BUSINESSWIRE
    08 Jul 2025
    Share Share
    Sound Pharma to Present at Investor Conferences
    Sound Pharma to Present at Investor Conferences

    08 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250408233562/en/Sound-Pharma-to-Present-at-Upcoming-Life-Science-Investor-Conferences

    BUSINESSWIRE
    08 Apr 2025
    Share Share
    Sound Pharma To Present SPI-1005 Hearing Loss, Tinnitus Data
    Sound Pharma To Present SPI-1005 Hearing Loss, Tinnitus Data

    18 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250218637880/en

    BUSINESSWIRE
    18 Feb 2025
    Share Share
    Sound Pharma Announces Positive Phase 3 Meniere’s Disease Results
    Sound Pharma Announces Positive Phase 3 Meniere’s Disease Results

    10 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241210989946/en

    BUSINESSWIRE
    10 Dec 2024
    Share Share
    Sound Pharma Completes Phase 3 Study Of SPI-1005 For Meniere's
    Sound Pharma Completes Phase 3 Study Of SPI-1005 For Meniere's

    31 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240731095666/en

    BUSINESSWIRE
    31 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search